Chronic hepatitis showed a strong impact on the mutational landscape in liver cancer and the genetic diversity among biliary differentiated liver cancers, where recurrent mutations in TERT promoter, chromatin regulators (BAP1, PBRM1 and ARID2), a synapse organization gene (PCLO), IDH genes and KRAS were identified. This evidence concerns the gene PCLO and liver cancer.